Brooks Laboratories Limited (BOM:533543)
India · Delayed Price · Currency is INR 67.30
0.00 (0.00%)
At close: Jun 19, 2026
Brooks Laboratories Market Cap
Brooks Laboratories has a market cap or net worth of 1.96 billion as of June 18, 2026. Its market cap has decreased by -53.98% in one year.
Market Cap
1.96B
Enterprise Value
1.97B
Revenue
857.38M
Ranking
n/a
PE Ratio
7.99
Stock Price
67.30
Market Cap Chart
Since September 5, 2011, Brooks Laboratories's market cap has increased from 105.21M to 1.96B, an increase of 1,766.91%. That is a compound annual growth rate of 21.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 1.96B | -16.80% |
| Dec 31, 2025 | 2.36B | -50.07% |
| Dec 31, 2024 | 4.73B | 25.45% |
| Dec 29, 2023 | 3.77B | 39.59% |
| Dec 30, 2022 | 2.70B | 8.92% |
| Dec 31, 2021 | 2.48B | 51.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gennex Laboratories | 2.54B |
| Sat Kartar Life | 2.52B |
| Ambalal Sarabhai Enterprises | 2.50B |
| Kerala Ayurveda | 2.40B |
| Speciality Medicines | 1.84B |
| Coral Laboratories | 1.80B |
| Sanjivani Paranteral | 1.77B |
| Oxygenta Pharmaceutical | 1.76B |